Elabela peptide: an emerging target in therapeutics

Curr Drug Targets. 2022 Aug 26. doi: 10.2174/1389450123666220826160123. Online ahead of print.ABSTRACTElabela, a bioactive micropeptide, is recognized as the second endogenous ligand for Apelin receptor and is widely distributed in different tissues and organs. Elabela plays important role in various physiological processes such blood pressure control, heart morphogenesis, apoptosis, angiogenesis, cell proliferation, migration, etc. Elabela is also implicated in pathological conditions like cardiac dysfunctions, heart failure, hypertension, kidney diseases, cancer and CNS disorders. The association of Elabela with these disease conditions makes it a potential target for their therapy. This review summarizes physiological role of Elabela peptide as well as its implication in various disease conditions.PMID:36029072 | DOI:10.2174/1389450123666220826160123
Source: Current Drug Targets - Category: Drugs & Pharmacology Authors: Source Type: research